Page last updated: 2024-08-21

oxazoles and Hypertriglyceridemia

oxazoles has been researched along with Hypertriglyceridemia in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bénardeau, A; Hansen, BC; Meyer, M; Mizrahi, J; Sebokova, E; Tigno, XT	1
Aragoncillo, P; Cachofeiro, V; Cediel, E; de las Heras, N; Lahera, V; Oubiña, MP; Sanz-Rosa, D	1
Argenziano, L; De Luca, N; Fontana, D; Iovino, G; Izzo, R; Trimarco, B; Vecchione, C	1

Trials

1 trial(s) available for oxazoles and Hypertriglyceridemia

Article	Year
Haemodynamic and metabolic effects of rilmenidine in hypertensive patients with metabolic syndrome X. A double-blind parallel study versus amlodipine. Journal of hypertension, 2000, Volume: 18, Issue:10 Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Blood Glucose; Body Weight; Double-Blind Method; Female; Hemodynamics; Humans; Hypertension; Hypertriglyceridemia; Insulin; Male; Middle Aged; Oxazoles; Plasminogen Activator Inhibitor 1; Rilmenidine; Tissue Plasminogen Activator	2000

Article

Year

Haemodynamic and metabolic effects of rilmenidine in hypertensive patients with metabolic syndrome X. A double-blind parallel study versus amlodipine.

Journal of hypertension, 2000, Volume: 18, Issue:10

Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Blood Glucose; Body Weight; Double-Blind Method; Female; Hemodynamics; Humans; Hypertension; Hypertriglyceridemia; Insulin; Male; Middle Aged; Oxazoles; Plasminogen Activator Inhibitor 1; Rilmenidine; Tissue Plasminogen Activator

2000

Other Studies

2 other study(ies) available for oxazoles and Hypertriglyceridemia

Article	Year
Effects of aleglitazar, a balanced dual peroxisome proliferator-activated receptor α/γ agonist on glycemic and lipid parameters in a primate model of the metabolic syndrome. Cardiovascular diabetology, 2011, Jan-20, Volume: 10 Topics: Administration, Oral; Animals; Apolipoprotein A-I; Apolipoprotein A-II; Biomarkers; Blood Glucose; Cholesterol, HDL; Cholesterol, LDL; Disease Models, Animal; Eating; Glycated Hemoglobin; Hypertriglyceridemia; Hypoglycemic Agents; Hypolipidemic Agents; Insulin Resistance; Macaca mulatta; Male; Metabolic Syndrome; Obesity; Oxazoles; PPAR alpha; PPAR gamma; Prediabetic State; Thiophenes; Time Factors; Triglycerides; Weight Loss	2011
Comparison between the effects of mixed dyslipidaemia and hypercholesterolaemia on endothelial function, atherosclerotic lesions and fibrinolysis in rabbits. Clinical science (London, England : 1979), 2003, Volume: 104, Issue:4 Topics: Acetylcholine; Animals; Aorta; Arteriosclerosis; Bridged Bicyclo Compounds, Heterocyclic; Diet; Endothelium, Vascular; Enzyme Inhibitors; Fibrinolysis; Hypercholesterolemia; Hyperlipidemias; Hypertriglyceridemia; In Vitro Techniques; Male; Models, Animal; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Oxazoles; Plasminogen Activator Inhibitor 1; Rabbits; Thromboxane A2; Tissue Plasminogen Activator; Vasoconstrictor Agents	2003

Article

Year

Effects of aleglitazar, a balanced dual peroxisome proliferator-activated receptor α/γ agonist on glycemic and lipid parameters in a primate model of the metabolic syndrome.

Cardiovascular diabetology, 2011, Jan-20, Volume: 10

Topics: Administration, Oral; Animals; Apolipoprotein A-I; Apolipoprotein A-II; Biomarkers; Blood Glucose; Cholesterol, HDL; Cholesterol, LDL; Disease Models, Animal; Eating; Glycated Hemoglobin; Hypertriglyceridemia; Hypoglycemic Agents; Hypolipidemic Agents; Insulin Resistance; Macaca mulatta; Male; Metabolic Syndrome; Obesity; Oxazoles; PPAR alpha; PPAR gamma; Prediabetic State; Thiophenes; Time Factors; Triglycerides; Weight Loss

2011

Comparison between the effects of mixed dyslipidaemia and hypercholesterolaemia on endothelial function, atherosclerotic lesions and fibrinolysis in rabbits.

Clinical science (London, England : 1979), 2003, Volume: 104, Issue:4

Topics: Acetylcholine; Animals; Aorta; Arteriosclerosis; Bridged Bicyclo Compounds, Heterocyclic; Diet; Endothelium, Vascular; Enzyme Inhibitors; Fibrinolysis; Hypercholesterolemia; Hyperlipidemias; Hypertriglyceridemia; In Vitro Techniques; Male; Models, Animal; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Oxazoles; Plasminogen Activator Inhibitor 1; Rabbits; Thromboxane A2; Tissue Plasminogen Activator; Vasoconstrictor Agents

2003